261 related articles for article (PubMed ID: 33010149)
1. Microelimination of Hepatitis C Among People With Human Immunodeficiency Virus Coinfection: Declining Incidence and Prevalence Accompanying a Multicenter Treatment Scale-up Trial.
Doyle JS; van Santen DK; Iser D; Sasadeusz J; O'Reilly M; Harney B; Traeger MW; Roney J; Cutts JC; Bowring AL; Winter R; Medland N; Fairley CK; Moore R; Tee BK; Asselin J; El-Hayek C; Hoy JF; Matthews GV; Prins M; Stoové MA; Hellard ME
Clin Infect Dis; 2021 Oct; 73(7):e2164-e2172. PubMed ID: 33010149
[TBL] [Abstract][Full Text] [Related]
2. Microelimination or Not? The Changing Epidemiology of Human Immunodeficiency Virus-Hepatitis C Virus Coinfection in France 2012-2018.
Cotte L; Hocqueloux L; Lefebvre M; Pradat P; Bani-Sadr F; Huleux T; Poizot-Martin I; Pugliese P; Rey D; Cabié A;
Clin Infect Dis; 2021 Nov; 73(9):e3266-e3274. PubMed ID: 33400777
[TBL] [Abstract][Full Text] [Related]
3. Moving Towards Hepatitis C Microelimination Among People Living With Human Immunodeficiency Virus in Australia: The CEASE Study.
Martinello M; Yee J; Bartlett SR; Read P; Baker D; Post JJ; Finlayson R; Bloch M; Doyle J; Shaw D; Hellard M; Petoumenos K; Lin L; Marks P; Applegate T; Dore GJ; Matthews GV
Clin Infect Dis; 2020 Sep; 71(6):1502-1510. PubMed ID: 31585005
[TBL] [Abstract][Full Text] [Related]
4. Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIV.
Hosseini-Hooshyar S; Martinello M; Yee J; Read P; Baker D; Post JJ; Finlayson R; Bloch M; Doyle JS; Shaw D; Hellard M; Petoumenos K; Carson J; Dore GJ; Matthews GV;
AIDS; 2020 Jul; 34(9):1347-1358. PubMed ID: 32590433
[TBL] [Abstract][Full Text] [Related]
5. Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan.
Huang MH; Sun HY; Ho SY; Chang SY; Hsieh SM; Sheng WH; Chuang YC; Huang YS; Su LH; Liu WC; Su YC; Hung CC
World J Gastroenterol; 2021 Oct; 27(37):6277-6289. PubMed ID: 34712032
[TBL] [Abstract][Full Text] [Related]
6. Impact of Hepatitis C Virus Cure on Depressive Symptoms in the Human Immunodeficiency Virus-Hepatitis C Virus Coinfected Population in Canada.
Marathe G; Moodie EEM; Brouillette MJ; Lanièce Delaunay C; Cox J; Martel-Laferrière V; Gill J; Cooper C; Pick N; Vachon ML; Walmsley S; Klein MB;
Clin Infect Dis; 2023 Feb; 76(3):e702-e709. PubMed ID: 35789253
[TBL] [Abstract][Full Text] [Related]
7. The Incidence of Hepatitis C Among Gay, Bisexual, and Other Men Who Have Sex With Men in Australia, 2009-2019.
Harney BL; Sacks-Davis R; van Santen DK; Traeger M; Wilkinson AL; Asselin J; El-Hayek C; Fairley CK; Roth N; Bloch M; Matthews G; Donovan B; Guy R; Stoové M; Hellard ME; Doyle JS;
Clin Infect Dis; 2022 May; 74(10):1804-1811. PubMed ID: 34698338
[TBL] [Abstract][Full Text] [Related]
8. Can Australia Reach the World Health Organization Hepatitis C Elimination Goal by 2025 Among Human Immunodeficiency Virus-positive Gay and Bisexual Men?
Boettiger DC; Salazar-Vizcaya L; Dore GJ; Gray RT; Law MG; Callander D; Lea T; Rauch A; Matthews GV
Clin Infect Dis; 2020 Jan; 70(1):106-113. PubMed ID: 30816916
[TBL] [Abstract][Full Text] [Related]
9. Implementing a Surveillance-Based Approach to Create a Statewide Viral Clearance Cascade for Hepatitis C Among People With HIV and HCV Coinfection in Connecticut.
Wegener M; Brooks R; Speers S; Nichols L; Villanueva M
Public Health Rep; 2024; 139(2):208-217. PubMed ID: 37232422
[TBL] [Abstract][Full Text] [Related]
10. Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010-19: an analysis of data from a consortium of prospective cohort studies.
Sacks-Davis R; van Santen DK; Boyd A; Young J; Stewart A; Doyle JS; Rauch A; Mugglin C; Klein M; van der Valk M; Smit C; Jarrin I; Berenguer J; Lacombe K; Requena MB; Wittkop L; Leleux O; Bonnet F; Salmon D; Matthews GV; Guy R; Martin NK; Spelman T; Prins M; Stoove M; Hellard M;
Lancet HIV; 2024 Feb; 11(2):e106-e116. PubMed ID: 38224708
[TBL] [Abstract][Full Text] [Related]
11. Decline in Hepatitis C Virus (HCV) Incidence in Men Who Have Sex With Men Living With Human Immunodeficiency Virus: Progress to HCV Microelimination in the United Kingdom?
Garvey LJ; Cooke GS; Smith C; Stingone C; Ghosh I; Dakshina S; Jain L; Waters LJ; Mahungu T; Ferro F; Sood C; Freeman C; Phillips C; Dhairyawan R; Burholt R; Sharp H; Ullah S; Gilleece Y; Brown A; Orkin C; Rodger A; Bhagani S
Clin Infect Dis; 2021 Jan; 72(2):233-238. PubMed ID: 32211763
[TBL] [Abstract][Full Text] [Related]
12. Previous incarceration impacts access to hepatitis C virus (HCV) treatment among HIV-HCV co-infected patients in Canada.
Kronfli N; Nitulescu R; Cox J; Moodie EE; Wong A; Cooper C; Gill J; Walmsley S; Martel-Laferrière V; Hull MW; Klein MB;
J Int AIDS Soc; 2018 Nov; 21(11):e25197. PubMed ID: 30460791
[TBL] [Abstract][Full Text] [Related]
13. Direct-acting antiviral treatment against hepatitis C virus infection in HIV-Infected patients - "En route for eradication"?
Pradat P; Pugliese P; Poizot-Martin I; Valantin MA; Cuzin L; Reynes J; Billaud E; Huleux T; Bani-Sadr F; Rey D; Frésard A; Jacomet C; Duvivier C; Cheret A; Hustache-Mathieu L; Hoen B; Cabié A; Cotte L;
J Infect; 2017 Sep; 75(3):234-241. PubMed ID: 28579302
[TBL] [Abstract][Full Text] [Related]
14. What is needed to achieve HCV microelimination among HIV-infected populations in Andalusia, Spain: a modeling analysis.
Skaathun B; Borquez A; Rivero-Juarez A; Mehta SR; Tellez F; Castaño-Carracedo M; Merino D; Palacios R; Macías J; Rivero A; Martin NK
BMC Infect Dis; 2020 Aug; 20(1):588. PubMed ID: 32770955
[TBL] [Abstract][Full Text] [Related]
15. Liver Stiffness-Based Strategies Predict Absence of Variceal Bleeding in Cirrhotic Hepatitis C Virus-Infected Patients With and Without Human Immunodeficiency Virus Coinfection After Sustained Virological Response.
Corma-Gómez A; Macías J; Morano L; Rivero A; Téllez F; Ríos MJ; Santos M; Serrano M; Palacios R; Merino D; Real LM; De Los Santos I; Vera-Méndez FJ; Galindo MJ; Pineda JA;
Clin Infect Dis; 2021 Mar; 72(5):e96-e102. PubMed ID: 33211801
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C coinfection and extrahepatic cancer incidence among people living with HIV.
Willis SJ; Kim HN; Achenbach CJ; Cachay ER; Christopoulos KA; Crane HM; Franco RA; Hurt CB; Kitahata MM; Moore RD; Silverberg MJ; Tien PC; Westreich D; Marcus JL
HIV Med; 2022 Jul; 23(6):620-628. PubMed ID: 34951105
[TBL] [Abstract][Full Text] [Related]
17. Characterizing Persons With HIV/HCV Coinfection Who Remain Untreated for Hepatitis C at Four HIV Clinics in Connecticut (CT): Role of Multiple Overlapping Barriers at the Individual and Clinic System Levels.
Zhao A; Wegener M; Brooks R; Mininberg L; Helou E; Maughan A; Villanueva M
Health Promot Pract; 2023 Sep; 24(5):1029-1038. PubMed ID: 37439687
[No Abstract] [Full Text] [Related]
18. The rate of hepatitis C reinfection in Canadians coinfected with HIV and its implications for national elimination.
Young J; Wang S; Lanièce Delaunay C; Cooper CL; Cox J; Gill MJ; Hull M; Walmsley S; Wong A; Klein MB;
Int J Drug Policy; 2023 Apr; 114():103981. PubMed ID: 36893502
[TBL] [Abstract][Full Text] [Related]
19. Can Hepatitis C Virus (HCV) Direct-Acting Antiviral Treatment as Prevention Reverse the HCV Epidemic Among Men Who Have Sex With Men in the United Kingdom? Epidemiological and Modeling Insights.
Martin NK; Thornton A; Hickman M; Sabin C; Nelson M; Cooke GS; Martin TCS; Delpech V; Ruf M; Price H; Azad Y; Thomson EC; Vickerman P
Clin Infect Dis; 2016 May; 62(9):1072-1080. PubMed ID: 26908813
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C Virus Elimination in the Human Immunodeficiency Virus-Coinfected Population: Leveraging the Existing Human Immunodeficiency Virus Infrastructure.
Clement ME; Collins LF; Wilder JM; Mugavero M; Barker T; Naggie S
Infect Dis Clin North Am; 2018 Jun; 32(2):407-423. PubMed ID: 29778263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
